{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:43:30Z","timestamp":1791089010660,"version":"4.1.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"22","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypoxia is a hallmark of solid tumors, which may offer opportunities for targeted therapies of cancer; however, the mechanisms that link hypoxia to malignant transformation and tumor progression are not fully understood. Here, we show that up-regulation of the polyamine system promotes cancer cell survival during hypoxic stress. Hypoxia was found to induce polyamine transport and the key enzyme of polyamine biosynthesis, ornithine decarboxylase (ODC), in a variety of cancer cell lines. Increased ODC protein expression was shown in hypoxic, GLUT-1\u2013expressing regions of tumor spheroids and experimental tumors, as well as in clinical tumor specimens. Hypoxic induction of the polyamine system was dependent on antizyme inhibitor (i.e., a key positive regulator of ODC and polyamine transport), as shown by RNA interference experiments. Interestingly, depletion of the polyamines during hypoxia resulted in increased apoptosis, which indicates an essential role of the polyamines in cancer cell adaptation to hypoxic stress. These results were supported by experiments in an in vivo glioma tumor model, showing significantly enhanced antitumor effects of the antiangiogenic, humanized anti\u2013vascular endothelial growth factor (VEGF) antibody bevacizumab when used in combination with the well-established, irreversible inhibitor of ODC, \u03b1-difluoromethylornithine. Our results provide important insights into the hypoxic stress response in malignant cells and implicate combined targeting of VEGF and ODC as an alternative strategy to treat cancer disease. [Cancer Res 2008;68(22):9291\u2013301]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-2340","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T08:58:00Z","timestamp":1226653080000},"page":"9291-9301","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hypoxia-Mediated Induction of the Polyamine System Provides Opportunities for Tumor Growth Inhibition by Combined Targeting of Vascular Endothelial Growth Factor and Ornithine Decarboxylase"],"prefix":"10.1158","volume":"68","author":[{"given":"Katrin J.","family":"Svensson","sequence":"first","affiliation":[{"name":"1Division of Oncology, Department of Clinical Sciences, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E.","family":"Welch","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Clinical Sciences, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Kucharzewska","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Clinical Sciences, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Bengtson","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Clinical Sciences, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjurberg","sequence":"additional","affiliation":[{"name":"2Department of Oncology, Lund University Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Pa\u030ahlman","sequence":"additional","affiliation":[{"name":"4Division of Molecular Medicine, Department of Laboratory Medicine, Lund University, Malmo\u0308, Sweden; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerdy B.","family":"Ten Dam","sequence":"additional","affiliation":[{"name":"5Department of Biochemistry, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo","family":"Persson","sequence":"additional","affiliation":[{"name":"3Division of Biogenic Amines, Department of Experimental Medical Research, Lund University, Lund, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Belting","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Department of Clinical Sciences, and"},{"name":"2Department of Oncology, Lund University Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,11,14]]},"reference":[{"key":"2022061700411020800_B1","unstructured":"Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res\u20081998; 58: 1408\u201316."},{"key":"2022061700411020800_B2","doi-asserted-by":"crossref","unstructured":"Pouysse\u0301gur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature\u20082006; 441: 437\u201343.","DOI":"10.1038\/nature04871"},{"key":"2022061700411020800_B3","doi-asserted-by":"crossref","unstructured":"Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature\u20081996; 379: 88\u201391.","DOI":"10.1038\/379088a0"},{"key":"2022061700411020800_B4","unstructured":"Koong AC, Denko NC, Hudson KM, et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res\u20082000; 60: 883\u20137."},{"key":"2022061700411020800_B5","doi-asserted-by":"crossref","unstructured":"Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev\u20082004; 4: 437\u201347.","DOI":"10.1038\/nrc1367"},{"key":"2022061700411020800_B6","doi-asserted-by":"crossref","unstructured":"Fischer C, Jonckx B, Mazzone M, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell\u20082007; 131: 463\u201375.","DOI":"10.1016\/j.cell.2007.08.038"},{"key":"2022061700411020800_B7","doi-asserted-by":"crossref","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev\u20082003; 3: 721\u201332.","DOI":"10.1038\/nrc1187"},{"key":"2022061700411020800_B8","doi-asserted-by":"crossref","unstructured":"Ratcliffe PJ. Understanding hypoxia signalling in cells\u2014a new therapeutic opportunity? Clin Med\u20082006; 6: 573\u20138.","DOI":"10.7861\/clinmedicine.6-6-573"},{"key":"2022061700411020800_B9","doi-asserted-by":"crossref","unstructured":"Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ\u20082008; 15: 678\u201385.","DOI":"10.1038\/cdd.2008.21"},{"key":"2022061700411020800_B10","doi-asserted-by":"crossref","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med\u20082004; 350: 2335\u201342.","DOI":"10.1056\/NEJMoa032691"},{"key":"2022061700411020800_B11","doi-asserted-by":"crossref","unstructured":"Gerner EW, Meyskens FL, Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer\u20082004; 4: 781\u201392.","DOI":"10.1038\/nrc1454"},{"key":"2022061700411020800_B12","doi-asserted-by":"crossref","unstructured":"Casero RA, Jr., Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov\u20082007; 6: 373\u201390.","DOI":"10.1038\/nrd2243"},{"key":"2022061700411020800_B13","doi-asserted-by":"crossref","unstructured":"Hayashi S, Murakami Y, Masufuji S. Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem Sci\u20081996; 21: 27\u201330.","DOI":"10.1016\/S0968-0004(06)80024-1"},{"key":"2022061700411020800_B14","doi-asserted-by":"crossref","unstructured":"Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem\u20082006; 281: 14529\u201332.","DOI":"10.1074\/jbc.R500031200"},{"key":"2022061700411020800_B15","doi-asserted-by":"crossref","unstructured":"Keren-Paz A, Bercovich Z, Kahana C. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation. Biochem Soc Trans\u20082007; 35: 311\u20133.","DOI":"10.1042\/BST0350311"},{"key":"2022061700411020800_B16","doi-asserted-by":"crossref","unstructured":"Russell D, Snyder SH. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci U S A\u20081968; 60: 1420\u20137.","DOI":"10.1073\/pnas.60.4.1420"},{"key":"2022061700411020800_B17","doi-asserted-by":"crossref","unstructured":"Auvinen M, Paasinen A, Andersson LC, Ho\u0308ltta\u0308 E. Ornithine decarboxylase activity is critical for cell transformation. Nature\u20081992; 360: 355\u20138.","DOI":"10.1038\/360355a0"},{"key":"2022061700411020800_B18","unstructured":"Moshier JA, Dosescu J, Skunca M, Luk GD. Transformation of NIH\/3T3 cells by ornithine decarboxylase overexpression. Cancer Res\u20081993; 53: 2618\u201322."},{"key":"2022061700411020800_B19","unstructured":"Clifford A, Morgan D, Yuspa SH, Soler AP, Gilmour S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res\u20081995; 55: 1680\u20136."},{"key":"2022061700411020800_B20","unstructured":"Fong LY, Feith DJ, Pegg AE. Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis. Cancer Res\u20082003; 63: 3945\u201354."},{"key":"2022061700411020800_B21","doi-asserted-by":"crossref","unstructured":"Guo Y, Cleveland JL, O'Brien TG. Haploinsufficiency for Odc modifies mouse skin tumor susceptibility. Cancer Res\u20082005; 65: 1146\u20139.","DOI":"10.1158\/0008-5472.CAN-04-3244"},{"key":"2022061700411020800_B22","doi-asserted-by":"crossref","unstructured":"Keren-Paz A, Bercovich Z, Porat Z, Erez O, Brener O, Kahana C. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions. Oncogene\u20082006; 25: 5163\u201372.","DOI":"10.1038\/sj.onc.1209521"},{"key":"2022061700411020800_B23","doi-asserted-by":"crossref","unstructured":"Nilsson JA, Keller UB, Baudino TA, et al. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell\u20082005; 7: 433\u201344.","DOI":"10.1016\/j.ccr.2005.03.036"},{"key":"2022061700411020800_B24","unstructured":"O'Brien TG. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res\u20081976; 36: 2644\u201363."},{"key":"2022061700411020800_B25","unstructured":"Hietala OA, Yum KY, Pilon J, et al. Properties of ornithine decarboxylase in human colorectal adenocarcinomas. Cancer Res\u20081990; 50: 2088\u201394."},{"key":"2022061700411020800_B26","unstructured":"Okuzumi J, Yamane T, Kitao Y, et al. Increased mucosal ornithine deacarboxylase activity in human gastric cancer. Cancer Res\u20081991; 51: 1448\u201351."},{"key":"2022061700411020800_B27","unstructured":"Lan L, Trempus C, Gilmour SK. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC\/Ras transgenic mice. Cancer Res\u20082000; 60: 5696\u2013703."},{"key":"2022061700411020800_B28","doi-asserted-by":"crossref","unstructured":"Wallace HM, Fraser AV. Inhibitors of polyamine metabolism: review article. Amino Acids\u20082004; 26: 353\u201365.","DOI":"10.1007\/s00726-004-0092-6"},{"key":"2022061700411020800_B29","doi-asserted-by":"crossref","unstructured":"Tang X, Kim AL, Feith DJ, et al. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+\/\u2212 mice. J Clin Invest\u20082004; 113: 867\u201375.","DOI":"10.1172\/JCI200420732"},{"key":"2022061700411020800_B30","doi-asserted-by":"crossref","unstructured":"Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH. Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci\u20082000; 20: 4099\u2013111.","DOI":"10.1523\/JNEUROSCI.20-11-04099.2000"},{"key":"2022061700411020800_B31","doi-asserted-by":"crossref","unstructured":"Persson L. Antibodies to ornithine decarboxylase. Immunochemical cross-reactivity. Acta Chem Scand B\u20081982; 36: 685\u20138.","DOI":"10.3891\/acta.chem.scand.36b-0685"},{"key":"2022061700411020800_B32","doi-asserted-by":"crossref","unstructured":"Pilz RB, Steglich C, Scheffler IE. Molecular and genetic characterization of an ornithine decarboxylase-deficient Chinese hamster cell line. J Biol Chem\u20081990; 265: 8880\u20136.","DOI":"10.1016\/S0021-9258(19)38970-7"},{"key":"2022061700411020800_B33","doi-asserted-by":"crossref","unstructured":"Belting M, Persson S, Fransson LA. Proteoglycan involvement in polyamine uptake. Biochem J\u20081999; 338: 317\u201323.","DOI":"10.1042\/bj3380317"},{"key":"2022061700411020800_B34","doi-asserted-by":"crossref","unstructured":"Mani K, Sandgren S, Lilja J, et al. HIV-Tat protein transduction domain specifically attenuates growth of polyamine deprived tumour cells. Mol Cancer Ther\u20082007; 6: 782\u20138.","DOI":"10.1158\/1535-7163.MCT-06-0370"},{"key":"2022061700411020800_B35","doi-asserted-by":"crossref","unstructured":"Seiler N, Kno\u0308dgen B. High-performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives. J Chromatogr\u20081980; 221: 227\u201335.","DOI":"10.1016\/S0378-4347(00)84307-8"},{"key":"2022061700411020800_B36","doi-asserted-by":"crossref","unstructured":"Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood\u20081993; 82: 3610\u20135.","DOI":"10.1182\/blood.V82.12.3610.bloodjournal82123610"},{"key":"2022061700411020800_B37","doi-asserted-by":"crossref","unstructured":"Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-\u03b1 and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-\u03b1. J Biol Chem\u20082003; 278: 15911\u20136.","DOI":"10.1074\/jbc.M300463200"},{"key":"2022061700411020800_B38","unstructured":"Airley R, Loncaster J, Davidson S, et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res\u20082001; 7: 928\u201334."},{"key":"2022061700411020800_B39","doi-asserted-by":"crossref","unstructured":"Mandel JL, Flintoff WF. Isolation of mutant mammalian cells altered in polyamine transport. J Cell Physiol\u20081978; 97: 335\u201343.","DOI":"10.1002\/jcp.1040970308"},{"key":"2022061700411020800_B40","unstructured":"Welch JE, Bengtson P, Svensson K, et al. Single chain fragment anti-heparan sulfate antibody targets the polyamine transport system and attenuates polyamine-dependent cell proliferation. Int J Oncol\u20082008; 32: 749\u201356."},{"key":"2022061700411020800_B41","doi-asserted-by":"crossref","unstructured":"Bercovich Z, Kahana C. Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme. J Biol Chem\u20082004; 279: 54097\u2013102.","DOI":"10.1074\/jbc.M410234200"},{"key":"2022061700411020800_B42","doi-asserted-by":"crossref","unstructured":"Mitchell JL, Simkus CL, Thane TK, et al. Antizyme induction mediates feedback limitation of the incorporation of specific polyamine analogues in tissue culture. Biochem J\u20082004; 384: 271\u20139.","DOI":"10.1042\/BJ20040972"},{"key":"2022061700411020800_B43","unstructured":"Shimizu S, Eguchi Y, Kamiike W, et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res\u20081996; 56: 2161\u20136."},{"key":"2022061700411020800_B44","unstructured":"Levin VA, Hess KR, Choucair A, et al. Phase III randomized study of postradiotherapy chemotherapy with combination \u03b1-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res\u20082003; 9: 981\u201390."},{"key":"2022061700411020800_B45","doi-asserted-by":"crossref","unstructured":"Levin VA, Jochec JL, Shantz LM, Aldape KD. Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO-PCV chemotherapy. Int J Cancer\u20082007; 121: 2279\u201383.","DOI":"10.1002\/ijc.22914"},{"key":"2022061700411020800_B46","doi-asserted-by":"crossref","unstructured":"Evans SM, Judy KD, Dunphy I, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res\u20082004; 10: 8177\u201384.","DOI":"10.1158\/1078-0432.CCR-04-1081"},{"key":"2022061700411020800_B47","doi-asserted-by":"crossref","unstructured":"Selvakumaran M, Yao KS, Feldman MD, O'Dwyer PJ. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis. Biochem Pharmacol\u20082008; 75: 627\u201338.","DOI":"10.1016\/j.bcp.2007.09.029"},{"key":"2022061700411020800_B48","doi-asserted-by":"crossref","unstructured":"Longo LD, Packianathan S, McQueary J, Stagg RB, Byus C, Cain C. Acute hypoxia increases ornithine decarboxylase activity and polyamine concentrations in fetal rat brain. Proc Natl Acad Sci U S A\u20081993; 90: 692\u20136.","DOI":"10.1073\/pnas.90.2.692"},{"key":"2022061700411020800_B49","unstructured":"Auvinen M, Laine A, Paasinen-Sohns A, et al. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res\u20081997; 57: 3016\u201325."},{"key":"2022061700411020800_B50","doi-asserted-by":"crossref","unstructured":"Vredenburgh JJ, Desjardins A, Herndon JE III, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol\u20082007; 25: 4722\u20139.","DOI":"10.1200\/JCO.2007.12.2440"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/22\/9291\/2600480\/9291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/22\/9291\/2600480\/9291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:15:55Z","timestamp":1655446555000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/22\/9291\/542776\/Hypoxia-Mediated-Induction-of-the-Polyamine-System"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,14]]},"references-count":50,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2008,11,14]]},"published-print":{"date-parts":[[2008,11,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-2340","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,14]]}}}